Chiappini Elena, Orlandi Michela, Chiarugi Alberto, Di Mauro Antonio, Insalaco Antonella, Milani Gregorio Paolo, Vallini Monica, Lo Vecchio Andrea
Department of Health Sciences, Pediatric Infectious Diseases Unit Meyer Children's University Hospital, IRCCS, University of Florence, Florence, Italy.
Department of Health Sciences, University of Florence, Florence, Italy.
Front Pediatr. 2024 Nov 1;12:1452226. doi: 10.3389/fped.2024.1452226. eCollection 2024.
Fever is a common symptom in children, but despite existing guidelines, pediatricians may not fully apply recommendations. Fever of Unknown Origin (FUO) is generally referred to as an unexplained prolonged fever. However, a standardized FUO definition and management is missing.
To collect updated data on the approach to fever and FUO among Italian pediatricians.
A cross-sectional anonymous survey was conducted among a large sample of primary care and hospital pediatricians. The panel group formulated and proposed a practical FUO definition, using a modified Delphi approach. A 75% consensus was required to reach an agreement.
Among 620 respondents, paracetamol was the first-choice antipyretic for 97.7% of participants, followed by ibuprofen; 38.4% prescribed antipyretics based on a specific body temperature rather than on child's discomfort, while physical methods were almost completely abandoned. Alternate treatment was recommended by 19.8% (123/620) of participants, 16.9% (105/620) would prescribe antipyretics to prevent adverse events following immunization. Regarding FUO diagnosis, 58.3% (362/620) considered as cut-off a body temperature above 38°C; the duration required was one week according to 36.45% (226/620) of participants, two weeks according to 35.32% (219/620). The FUO definition proposed by the expert panel reached 81% of consent. Large agreement was observed on first-level laboratory and instrumental investigations in the diagnostic evaluation of FUO, whereas more discrepancies arose on second and third-level investigations. Compared to what participants reported for the treatment of non-prolonged fever, a significant decrease in the prescription of paracetamol as first-choice drug in children with FUO was observed (80.5%; < 0.0001). Interestingly, 39% of participants would empirically recommend antibiotics, 13.7% steroids, and 4.5% Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) for persistent FUO.
Non-recommended behaviors in fever management persist among pediatricians, including alternating use of paracetamol and ibuprofen, and their prophylactic use for vaccinations. Our data confirm the variability in the definition, work-up, and management of FUO. We observed that in children with FUO paracetamol was significantly less commonly preferred than in non-prolonged fever, which is not supported by evidence. Our findings combined with evidence from existing literature underlined the need for future consensus documents.
发热是儿童常见症状,但尽管有现有指南,儿科医生可能并未充分应用相关建议。不明原因发热(FUO)通常指无法解释的持续性发热。然而,目前缺少标准化的FUO定义和管理方法。
收集意大利儿科医生对发热及FUO处理方法的最新数据。
对大量基层医疗和医院儿科医生进行了一项横断面匿名调查。专家小组采用改良德尔菲法制定并提出了一个实用的FUO定义。需达成75%的共识才能达成一致。
在620名受访者中,97.7%的参与者首选对乙酰氨基酚作为退烧药,其次是布洛芬;38.4%的人根据特定体温而非孩子的不适来开退烧药,而物理方法几乎完全被摒弃。19.8%(123/620)的参与者推荐了替代治疗方法,16.9%(105/620)的人会为预防免疫接种后的不良事件而开退烧药。关于FUO诊断,58.3%(362/620)的人认为体温高于38°C为临界值;36.45%(226/620)的参与者认为所需持续时间为一周,35.32%(219/620)的人认为是两周。专家小组提出的FUO定义达成了81%的共识。在FUO诊断评估的一级实验室和仪器检查方面观察到了高度一致性,而在二级和三级检查方面出现了更多差异。与参与者报告的非持续性发热治疗情况相比,FUO儿童中作为首选药物的对乙酰氨基酚处方量显著下降(80.5%;<0.0001)。有趣的是,39%的参与者会经验性地推荐抗生素,13.7%推荐类固醇,4.5%推荐非甾体抗炎药(NSAIDs)用于持续性FUO。
儿科医生在发热管理中仍存在不推荐的行为,包括交替使用对乙酰氨基酚和布洛芬以及将其用于预防接种。我们的数据证实了FUO在定义、检查和管理方面的变异性。我们观察到,与非持续性发热儿童相比,FUO儿童中对乙酰氨基酚的首选率显著较低,这并无证据支持。我们的研究结果与现有文献证据共同强调了未来制定共识文件的必要性。